Importance Colorectal cancer (CRC) is the third most common cause of cancer mortality
worldwide with more than 1.85 million cases and 850 000 deaths annually. Of new …

Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

Treatment of Metastatic Colorectal Cancer: ASCO Guideline - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Colon Cancer focuses on systemic therapy options for the treatment of metastatic …

In tumor-bearing mice, cyclic fasting or fasting-mimicking diets (FMD) enhance the activity of
antineoplastic treatments by modulating systemic metabolism and boosting antitumor …

PURPOSE A proper estimation of the magnitude of the overall survival (OS) benefit from
infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus …

Over the past two decades of successive clinical trials in metastatic colorectal cancer (CRC),
the median overall survival of both control and experimental arms has steadily improved …

Background Immune checkpoint inhibitors have not shown clinical benefit to patients with
metastatic colorectal cancer who had proficient mismatch repair (pMMR) or microsatellite …

Background Colorectal cancer (CRC) is still a leading cause of cancer-related deaths in the
United States and worldwide, despite recent improvements in cancer management. CRC …